The “Collaborative Efforts African Stakeholder Engagement for Combating Invasive Salmonella Infection Meeting” will be held in Kinshasa, Democratic Republic of Congo, from December 3rd to…
IPNC is the premier event for the scientific community working on the pathogenic Neisseria species, including Neisseria meningitidis and Neisseria gonorrhoeae. The conference will feature…
OPEN CALL Sub-Topic 1 Recall of memory responses, or formation of new antibody responses, following sequential exposures to variable viruses such as influenza OPEN CALL…
Global Sustainability Forum within the Global Sustainable Technology & Innovation Community congress
Grateful and proud to be invited and present at the Global Sustainability Forum within the Global Sustainable Technology & Innovation Community congress that took place…
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 33 million to support Inno4vac, an innovative public-private partnership to accelerate vaccine R&D…
Transforming Vaccinology (L2) Scientific Organizers: Rino Rappuoli, Lynda M. Stuart and Federica Sallusto March 15—19, 2020 Firenze Fiera- Fortezza da Basso, Florence, Italy For more information,…
Conference on “Vaccini. La ricerca per la salute globale” in the context of the series of meetings “Studium”; Siena, Aula Magna storica del Rettorato, 30th May…
Researchers have announced that the rVSV-ZEBOV vaccine has shown 100 % effectiveness in a Phase III large-scale trial of over 7000 people in Guinea. Read the full paper
With an emphasis on systems analyses, the VSV-EBOVAC project harnesses state-of-theart technologies that illuminate mechanisms behind the observed immunogenicity and reactogenicity of the rVSV-ZEBOV vaccine…
The Science and Technology Options Assessment (STOA) of the European Parliament, organizes an event “Working Breakfast on Vaccine Research and Development in Europe”. This is…